Biblio

Export 6315 results:
Author Title Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Aged
Y. Moon, Han, S. - H., and Moon, W. - J., “Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.”, J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, “Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, “Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., “Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., “Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., “Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., “Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.”, J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., “Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.”, J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., “Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.”, J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., “Spatial Navigation in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
A. L. Jefferson, Gifford, K. A., Mae Y Acosta, L., Bell, S. P., Donahue, M. J., L Davis, T., Gottlieb, J. A., Gupta, D. K., Hohman, T. J., Lane, E. M., Libon, D. J., Mendes, L. A., Niswender, K., Pechman, K. R., Rane, S., Ruberg, F. L., Su, Y. Ru, Zetterberg, H., and Liu, D., “The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.”, J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., “Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., “Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.”, J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
J. H. Lingler, Butters, M. A., Gentry, A. L., Hu, L., Hunsaker, A. E., Klunk, W. E., Mattos, M. K., Parker, L. A., J Roberts, S., and Schulz, R., “Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 17-24, 2016.
J. H. Lingler, Butters, M. A., Gentry, A. L., Hu, L., Hunsaker, A. E., Klunk, W. E., Mattos, M. K., Parker, L. A., J Roberts, S., and Schulz, R., “Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 17-24, 2016.
G. Faxen-Irving, Falahati, F., Basun, H., Eriksdotter, M., Vedin, I., Wahlund, L. - O., Schultzberg, M., Hjorth, E., Palmblad, J., Cederholm, T., and Freund-Levi, Y., “Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?”, J Alzheimers Dis, vol. 61, no. 2, pp. 515-519, 2018.
E. Portacolone, Johnson, J. K., Covinsky, K. E., Halpern, J., and Rubinstein, R. L., “The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1517-1529, 2018.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., “Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1.”, J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., “Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1.”, J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.

Pages